04:54 PM EDT, 04/10/2025 (MT Newswires) -- BioCryst Pharmaceuticals ( BCRX ) late Thursday appointed Jon P. Stonehouse, its chief executive officer as chief financial officer and principal accounting officer on an interim basis, after Anthony Doyle stepped down from the positions earlier this week.

BioCryst also said Doyle will continue to work with the company through May 31 as a paid consultant assisting with the transition.

It also has hired the former CFO at a publicly traded biotechnology company to help with its financial reporting during the search for a permanent CFO. The identity of the executive was not revealed.